Systemic sclerosis trial design moving forward

    loading  Checking for direct PDF access through Ovid


The 2013 American College of RheumatologyCEuropean League Against Rheumatism (ACRCEULAR) classification criteria for systemic sclerosis (SSc) have shifted the construct of SSc. The new reality is that patients recruited for trials may not be so severe and not so advanced. We can now look for therapeutics that might stop disease evolution and/or prevent organ involvement. This article highlights recent advances in research methodology, and broadens the potential range of design and analytic considerations when planning an SSc trial.

Related Topics

    loading  Loading Related Articles